<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03685006</url>
  </required_header>
  <id_info>
    <org_study_id>REK 2009/5237</org_study_id>
    <nct_id>NCT03685006</nct_id>
  </id_info>
  <brief_title>Atherosclerosis and Acute Ischemic Stroke Study</brief_title>
  <official_title>Carotid Atherosclerosis, Inflammation and Ischemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Akershus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ostfold Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vestre Viken Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A significant proportion of strokes are thromboembolic in nature, arising from&#xD;
      atherosclerotic plaque at the carotid bifurcation. It is now wellknown that inflammation&#xD;
      plays a key role in atherogenesis and plaque destabilization. However the identification and&#xD;
      characterization of the different inflammatory factors, as well as their relative importance,&#xD;
      have not been clarified. This main aim of this study is to identify new risk markers for&#xD;
      atherosclerosis and to characterize more precise methods for detection of the unstable&#xD;
      carotid plaque with increased stroke-risk.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project include patients with asymptomatic and symptomatic carotid stenosis &gt;50%.&#xD;
      Patients with acute ischemic stroke will also be included with carotid artery stenosis &lt;50%&#xD;
      (study 3). The patient group will undergo a clinical neurological examination, ultrasound of&#xD;
      the neck-arteries and a blood sample. The majority will also have a CT-angiography of the&#xD;
      neck arteries and a cerebral MRI or CT. Carotid plaques removed by surgery (carotid&#xD;
      end-arterectomy) and thrombs removed by thrombectomy will undergo histological analyses.&#xD;
&#xD;
      Study 1:&#xD;
&#xD;
      Plasma markers will be analysed and compared to clinical symptoms, ultrasound assessment of&#xD;
      the plaque, cerebral MRI (or CT).&#xD;
&#xD;
      Study 2:&#xD;
&#xD;
      Results from advanced ultrasound of the carotid plaque including assessment of plaque&#xD;
      morphology will be compared to histology of the removed plaque. Plasma markers and clinic&#xD;
      will be related to the findings. The correlation between the different diagnostic modalities&#xD;
      and the histologic conclusion will be assessed.&#xD;
&#xD;
      Study 3:&#xD;
&#xD;
      This study focus on plasma markers in an acute ischemic stroke due to a carotid plaque&#xD;
      compared to an acute ischemic stroke with a cardial embolic source. Thrombi removed from the&#xD;
      cerebral artery by thrombectomy will undergo histological analysis and the results will be&#xD;
      compared to plasma markers and stroke aetiology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2009</start_date>
  <completion_date type="Anticipated">January 1, 2030</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Plasma markers and advanced ultrasound of neck arteries to detect plaque instability, predict stroke risk and correlation to stroke aetiology.</measure>
    <time_frame>one year</time_frame>
    <description>Blood test, ultrasound, cerebral MRI, clinical assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma markers to predict plaque instability</measure>
    <time_frame>At inclusion</time_frame>
    <description>Blood test, ultrasound, cerebral MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Advanced ultrasound for detection of carotid plaque instability</measure>
    <time_frame>At inclusion and after one year</time_frame>
    <description>Ultrasound, blood test, cerebral MRI, histology of carotid artery plaques</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma markers to determine correlation of acute ischemic stroke due to a carotid plaque compared to an acute ischemic stroke with a cardial embolic source</measure>
    <time_frame>At inclusion</time_frame>
    <description>Blood tests, ultrasound of neck arteries, cerebral MRI, histology of removed cerebral thrombi</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Inflammation</condition>
  <condition>Ischemic Stroke</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Carotid artery plaques removed by carotid endartrectomy Plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with carotid atherosclerosis and/ or cerebrovascular symptoms/ disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients with an atherosclerotic carotid stenosis &gt;50% admitting one of the study&#xD;
             centres as an in-patient or an out-patient will be considered for inclusion.&#xD;
&#xD;
          -  Acute stroke patients treated with thrombectomy at Oslo University Hospital will be&#xD;
             included even though the carotid stenosis is &lt; 50%.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Malign disease&#xD;
&#xD;
          -  Inflammatory disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mona Skjelland, MD/postdoc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital, Oslo, Norway</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 10, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Mona Skjelland</investigator_full_name>
    <investigator_title>Consultant, Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

